Decreasing glucose resorption from the GIT (galactomannan)
Molecular Characteristics Molecular Type: Synthetic relaxin-derived research peptide Structure: Linear peptide chain CAS Identifier: Not Assigned (N/A) Form: Lyophilized powder Stability: High when stored under recommended laboratory conditions Stability Profile and Storage Recommendations Supplied as a lyophilized powder for enhanced long-term stability Recommended storage at 20C Protect from moisture and prolonged light exposure Avoid repeated freezethaw cycles Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Options Bacteriostatic water Sterile saline solutions Buffered aqueous solutions Acidic buffer systems Compatible analytical-grade organic solvents Technical Specifications product Name B7-33 6mg cas Not Assigned (N/A) purity 99% (HPLC verified) unit Size 6 mg form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear synthetic peptide stability High when stored appropriately Analytical Validation and Quality Assurance High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity verification UV spectrophotometric concentration analysis Batch-to-batch reproducibility validation Microbial and endotoxin screening Regulatory and Compliance Statement B7-33 6mg is supplied strictly for laboratory research use only
Prominent features include epithelial barrier dysfunction, delayed or accelerated gastrointestinal transit due to abnormal function of smooth muscles, dysfunctional enteric nervous system and/or immunity, gut microbial dysbiosis, bile acid malabsorption, and alterations in the gut-brain axis (812)
Glutenfrei, laktosefrei und ohne knstliche Farbstoffe
This leads to wheezing, chest tightness, and difficulty breathing
Serum concentrations of interleukin-6 in patients following unilateral versus bilateral total knee arthroplasty
